Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-002371
Filing Date
2021-01-06
Accepted
2021-01-06 19:15:07
Documents
1
Period of Report
2021-01-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3433
  Complete submission text file 0001209191-21-002371.txt   4886
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Issuer) CIK: 0001681682 (see all company filings)

EIN.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3845 Electromedical & Electrotherapeutic Apparatus

Mailing Address 10 ACORN WAY GEORGETOWN MA 01833
Business Address
Maloberti Renaud Bertrand (Reporting) CIK: 0001744025 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37969 | Film No.: 21512395